A clinical practice guideline for the management of degenerative cervical myelopathy: introduction, rationale, and scope

Simple item page
dc.contributor.authorFehlings, Michael G.
dc.contributor.authorTetreault, Lindsay A.
dc.contributor.authorRiew, K. Daniel
dc.contributor.authorMiddleton, James W.
dc.contributor.authorWang, Jeffrey C.
dc.contributor.funderAOSpine
dc.contributor.funderCervical Spine Research Society
dc.contributor.funderGerald and Tootsie Halbert Chair in Neural Repair and Regeneration
dc.contributor.funderDeZwirek Family Foundation
dc.contributor.funderKrembil Foundation
dc.date.accessioned2018-03-09T12:55:06Z
dc.date.available2018-03-09T12:55:06Z
dc.date.issued2017
dc.description.abstractDegenerative cervical myelopathy (DCM) is a progressive spine disease and the most common cause of spinal cord dysfunction in adults worldwide. Patients with DCM may present with common signs and symptoms of neurological dysfunction, such as paresthesia, abnormal gait, decreased hand dexterity, hyperreflexia, increased tone, and sensory dysfunction. Clinicians across several specialties encounter patients with DCM, including primary care physicians, rehabilitation specialists, therapists, rheumatologists, neurologists, and spinal surgeons. Currently, there are no guidelines that outline how to best manage patients with mild (defined as a modified Japanese Orthopedic Association (mJOA) score of 15-17), moderate (mJOA = 12-14), or severe (mJOA <= 11) myelopathy, or nonmyelopathic patients with evidence of cord compression. This guideline provides evidencebased recommendations to specify appropriate treatment strategies for these populations. The intent of our recommendations is to (1) help identify patients at high risk of neurological deterioration, (2) define the role of nonoperative and operative management in each patient population, and (3) determine which patients are most likely to benefit from surgical intervention. The ultimate goal of these guidelines is to improve outcomes and reduce morbidity in patients with DCM by promoting standardization of care and encouraging clinicians to make evidence-informed decisions.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationFehlings, M. G., Tetreault, L. A., Riew, K. D., Middleton, J. W. and Wang, J. C. (2017) 'A clinical practice guideline for the management of degenerative cervical myelopathy: introduction, rationale, and scope', Global Spine Journal, 7(3s), pp. 21-27. doi: 10.1177/2192568217703088en
dc.identifier.doi10.1177/2192568217703088
dc.identifier.endpage27
dc.identifier.issn2192-5682
dc.identifier.issued3S
dc.identifier.journaltitleGlobal Spine Journalen
dc.identifier.startpage21
dc.identifier.urihttps://hdl.handle.net/10468/5592
dc.identifier.volume7
dc.language.isoenen
dc.publisherSage Publicationsen
dc.relation.urihttp://journals.sagepub.com/doi/10.1177/2192568217703088
dc.rights© 2017, the Authors. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (http://www.creativecommons.org/licenses/by-nc-nd/4.0/ ) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).en
dc.rights.urihttp://www.creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCervical spondylotic myelopathyen
dc.subjectDegenerative cervical myelopathyen
dc.subjectGuideline developmenten
dc.subjectGuidelinesen
dc.titleA clinical practice guideline for the management of degenerative cervical myelopathy: introduction, rationale, and scopeen
dc.typeOtheren
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
3776.pdf
Size:
186.92 KB
Format:
Adobe Portable Document Format
Description:
Published Version
Download
Collections
Medicine - Journal Articles